The Brain as a Drug Target

Shafiqur Rahman, Ph.D. is Professor of Pharmacology in the Department of Pharmaceutical Sciences at South Dakota State University (SDSU) in Brookings, USA. He received his Ph.D. in Neuropharmacology from the Memorial University of Newfoundland, Canada. Dr. Rahman completed his post-doctoral fellowship in the Department of Psychiatry from Indiana University School of Medicine in Indianapolis in USA. Prior to joining SDSU, he worked as research scientist and faculty at the University of Kentucky in Lexington, USA and the University of Toronto, Canada. Dr. Rahman's research focus is drug discovery in neuropharmacology, i.e. the development of novel therapeutic candidates for the treatment of drug addiction and neuropsychiatric disorders. His research and scholarship has resulted in over 125 publications and 11 edited books/book chapters. Dr. Rahman served as editor, editorial board member and reviewer for numerous Scientific Journals and review panels related to drug addiction, neuropharmacology, and drug discovery research. Dr. Rahman is also a member of several professional societies or organizations, including Society for Neuroscience, American Society for Experimental Neurotherapeutics, and American Society for Pharmacology and Experimental Therapeutics.

PRAISE FOR THE SERIES "Full of interest not only for the molecular biologist--for whom the numerous references will be invaluable--but will also appeal to a much wider circle of biologists, and in fact to all those who are concerned with the living cell." --British Medical Journal

• 1. Monoamine Transporters: Vulnerable and Vital DoorkeepersZhicheng Lin, Juan J. Canales, Thröstur Björgvinsson, Morgane M. Thomsen, Hong Qu, Qing-Rong Liu, Gonzalo E. Torres, and S. Barak Caine2. Therapeutic Targets in Alzheimer Disease and Related TauopathiesChristopher P. Corbo and Alejandra del C. Alonso3. Therapeutic Targets for Neuroprotection and/or Enhancement of Functional Recovery Following Traumatic Brain InjuryMatthew L. Kelso and James R. Pauly4. Insulin, Synaptic Function, and Opportunities for NeuroprotectionJohn G. Mielke and Yu-Tian Wang5. Molecular Alterations in Glioblastoma: Potential Targets for ImmunotherapyAzizul Haque, Naren L. Banik, and Swapan K. Ray6. Molecular Signaling and Translational Significance of the Corticotropin Releasing Factor SystemPatrick J. Ronan, and Cliff H. Summers7. Molecular targets of alcohol action: translational research for pharmacotherapy development and screeningGiorgio Gorini, Richard L. Bell, and R. Dayne Mayfield8. Brain Nicotinic Receptors as Emerging Targets for Drug Addiction: Neurobiology to Translational ResearchShafiqur Rahman9. Glutamatergic Neuroplasticity in Cocaine AddictionJoachim D. Uys and Kathryn J. Reissner10. Role of the serotonergic system in alcohol dependence: from animal models to clinicsVerity R. Johnson, Jason M. Weedman, Youssef Sari